Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupesh Dash

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|September 9, 2025
NEK9-mediated Wnt signalling repressor TLE3 rewires Docetaxel resistance in cancer cells by inducing pyroptosisShamima Azma Ansari, Sibasish Mohanty, Pallavi Mohapatra, et al.
Oncotarget|May 1, 2015
Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimeticSiddik Sarkar, Bridget A Quinn, Xue-Ning Shen, et al.
Expert Opinion on Therapeutic Targets|November 24, 2012
Targeting the Bcl-2 family for cancer therapyShibu Thomas, Bridget A Quinn, Swadesh K Das, et al.
Molecular Cancer Therapeutics|January 8, 2010
Astrocyte elevated gene-1: a novel target for human glioma therapyLuni Emdad, Devanand Sarkar, Seok-Geun Lee, et al.
Cancer Research|April 22, 2010
Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24Sujit K Bhutia, Rupesh Dash, Swadesh K Das, et al.
JCI Insight|January 12, 2021
CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axisPallavi Mohapatra, Omprakash Shriwas, Sibasish Mohanty, et al.
Journal of Medicinal Chemistry|May 7, 2010
BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteinsJun Wei, John L Stebbins, Shinichi Kitada, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant gliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Cancer Research|January 28, 2010
PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cellsAdly Yacoub, Hossein A Hamed, Jeremy Allegood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2024
Retraction Notice to: Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant GliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|September 9, 2025
NEK9-mediated Wnt signalling repressor TLE3 rewires Docetaxel resistance in cancer cells by inducing pyroptosisShamima Azma Ansari, Sibasish Mohanty, Pallavi Mohapatra, et al.
Oncotarget|May 1, 2015
Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimeticSiddik Sarkar, Bridget A Quinn, Xue-Ning Shen, et al.
Expert Opinion on Therapeutic Targets|November 24, 2012
Targeting the Bcl-2 family for cancer therapyShibu Thomas, Bridget A Quinn, Swadesh K Das, et al.
Molecular Cancer Therapeutics|January 8, 2010
Astrocyte elevated gene-1: a novel target for human glioma therapyLuni Emdad, Devanand Sarkar, Seok-Geun Lee, et al.
Cancer Research|April 22, 2010
Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24Sujit K Bhutia, Rupesh Dash, Swadesh K Das, et al.
JCI Insight|January 12, 2021
CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axisPallavi Mohapatra, Omprakash Shriwas, Sibasish Mohanty, et al.
Journal of Medicinal Chemistry|May 7, 2010
BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteinsJun Wei, John L Stebbins, Shinichi Kitada, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant gliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Cancer Research|January 28, 2010
PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cellsAdly Yacoub, Hossein A Hamed, Jeremy Allegood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2024
Retraction Notice to: Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant GliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Pageof 8